CDNA Q3 2024 Earnings — CareDx, Inc Revenue & Financial Results | Market Cap Arena

CDNACareDx, Inc

$889M

Q3 2024 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$83M+23.4% YoY

Gross Profit

$55M66.7% margin

Operating Income

-$10M-12.7% margin

Net Income

-$7M-8.9% margin

EPS (Diluted)

$-0.14

QoQ Revenue Growth

-10.2%

Cash Flow

Operating Cash Flow

$13M

Free Cash Flow

$11M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$477M

Total Liabilities

$204M

Stockholders' Equity

$273M

Cash & Equivalents

$95M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$83M	$67M	+23.4%
Gross Profit	$55M	$43M	+29.7%
Operating Income	-$10M	-$29M	+63.5%
Net Income	-$7M	-$23M	+68.5%

Revenue Segments

Service

$61M86%

Product

$10M14%

Geographic Segments

UNITED STATES

$79M95%

Europe

$3M3%

Rest Of The World

$1M2%